Profile picture

Professor Jeanette Schulz-Menger

Charité - University Medicine Berlin, Berlin (Germany)
Membership: FESC Member EACVI Member EHRA Member
Follow
Biography
Professor Jeanette Schulz-Menger is a cardiologist and Professor of Cardiology at Charité – Universitätsmedizin Berlin, with a focus on CMR since 1996. She leads a high-volume clinical CMR center at Helios Berlin-Buch and has established both the nationwide HELIOS-CMR Network and a Charité-wide CMR research network. Her work connects clinical care, translational research and CMR education, with a focus on cardiomyopathies and inflammatory and rare cardiovascular diseases. She has contributed to more than 350 scientific publications and co-chaired the 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis. A Past President and Gold Medal recipient of SCMR, she has served on the boards of EACVI, ISMRM and DGK. She currently serves on the ESC Programme Committee and ESC Global Affairs Committee and leads the SCMR Past Presidents Committee. Outside medicine, she enjoys theatre, literature, skiing and time with family and friends.
Logo ESC

Contributor content

New insights into myocarditis and shock
Session
New insights into myocarditis and shock
28 August 2026
Cardiac magnetic resonance risk stratification across cardiomyopathies
Session
Cardiac magnetic resonance risk stratification across cardiomyopathies
28 August 2026
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
Session
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
30 August 2025
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis: Ask the Task Force
Session
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis: Ask the Task Force
30 August 2025
Guidelines in Practice: 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
Session
Guidelines in Practice: 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
30 August 2025
Great Debate: assessing the risk of sudden death in hypertrophic cardiomyopathy should include myocardial fibrosis imaging
Session
Great Debate: assessing the risk of sudden death in hypertrophic cardiomyopathy should include myocardial fibrosis imaging
1 September 2024
Guidelines in Practice: risk stratification for sudden cardiac death in non-dilated left ventricular cardiomyopathy
Session
Guidelines in Practice: risk stratification for sudden cardiac death in non-dilated left ventricular cardiomyopathy
30 August 2024
Angina with normal coronary arteries: do not forget microvascular disease
Session
Angina with normal coronary arteries: do not forget microvascular disease
27 August 2022
Clinical implications of new methods to assess cardiac function
Session
Clinical implications of new methods to assess cardiac function
27 August 2022
More insights from  imaging into outcome after COVID-19 infection
Session
More insights from imaging into outcome after COVID-19 infection
9 December 2021